Shuttle Pharmaceuticals Holdings (SHPH) Non Operating Investment Income (2023 - 2024)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Non Operating Investment Income came in at -$42898.0 in Q3 2024, down 546.58% year-on-year from $9606.0 in Q4 2023, and down 53.4% quarter-over-quarter from -$27964.0 in Q2 2024.
Shuttle Pharmaceuticals Holdings (SHPH) Non Operating Investment Income (2023 - 2024) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Non Operating Investment Income history runs 2 years deep, the most recent figure standing at -$42898.0 for Q3 2024.
- On a quarterly basis, Non Operating Investment Income fell 546.58% year-over-year to -$42898.0 in Q3 2024; TTM through Sep 2024 was -$21134.0, a N/A change from a year earlier, with the FY2023 full-year figure at $71568.0, changed N/A from the prior year.
- Non Operating Investment Income declined to -$42898.0 in Q3 2024 per SHPH's latest filing, from -$27964.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $50434.0 in Q4 2023 and bottomed at -$42898.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.82 Bn | 87.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.03 Bn | 32.29 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.02 Bn | 20.86 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.43 Bn | 18.63 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.73 Bn | 12.30 Bn | 785.00 Mn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -42,898.00 |
| Sep 30, 2024 | -42,898.00 |
| Jun 30, 2024 | -27,964.00 |
| Jun 30, 2024 | -27,964.00 |
| Mar 31, 2024 | -706.00 |
| Mar 31, 2024 | -706.00 |
| Dec 31, 2023 | 50,434.00 |
| Dec 31, 2023 | 50,434.00 |
| Sep 30, 2023 | 9,606.00 |
| Sep 30, 2023 | 9,606.00 |
| Jun 30, 2023 | -26,534.00 |
| Jun 30, 2023 | -26,534.00 |
| Mar 31, 2023 | 38,062.00 |
| Mar 31, 2023 | 38,062.00 |